Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)

NCT04106349 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Ipsen